monoclonal antibody
Trastuzumab
Treats a cancer. This molecule appears in 394 of the medicines we have indexed.
Do you need a supplement? No.
No supplement is warranted with this treatment. A varied diet remains the foundation.
Do you also take another treatment?
By the Layer Nutrition editorial teamHow the atlas classifies the 664 molecules
- Class
- monoclonal antibody anticancer
- Indexed medicines
- 394
- Our answer
- Nothing to add
- Updated
- October 2026
What this medicine is for
Pharmacologically, this molecule belongs to the “monoclonal antibody (anticancer)” category. This medicine belongs to the “Other fields” field. Its indication is precise and set by the prescription.
In practice: Treats a cancer. How it is used depends on the situation, within the framework set by the doctor.
The name on your box may be here.
These names come from the public registers of 32 countries: the ANSM for France, the AEMPS for Spain, the AIFA for Italy, the HPRA for Ireland, Swissmedic for Switzerland, and the European Medicines Agency for the others.
Most widespread
- HERCEPTIN SUBKUTAN
- ENHERTU
- HERCEPTIN
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- PHESGO
- TRAZIMERA
- ZERCEPAC
- ONTRUZANT
- DAZUBLYS
No name matches.
See all names, country by countryHide the list by country
France10
- ENHERTU
- HERCEPTIN
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- TRAZIMERA
- ZERCEPAC
- PHESGO
Germany13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Spain10
- ENHERTU
- HERCEPTIN
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- TRAZIMERA
- ZERCEPAC
- PHESGO
Italy13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- TRAZIMERA
- TUZNUE
- ZERCEPAC
- PHESGO
Ireland13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- TRAZIMERA
- TUZNUE
- ZERCEPAC
- PHESGO
Switzerland10
- ENHERTU
- HERCEPTIN
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- TRAZIMERA
- ZERCEPAC
- PHESGO
- HERCEPTIN SUBKUTAN
Austria13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Belgium13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Bulgaria13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Cyprus13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Croatia13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Denmark13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Estonia13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Finland13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Greece13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Hungary13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Iceland13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- TRAZIMERA
- TUZNUE
- ZERCEPAC
- ONTRUZANT
- PHESGO
Latvia13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Liechtenstein13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- OGIVRI
- TRAZIMERA
- TUZNUE
- ZERCEPAC
- KANJINTI
- ONTRUZANT
- PHESGO
Lithuania13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Luxembourg13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Malta13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Norway13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- TRAZIMERA
- TUZNUE
- ZERCEPAC
- ONTRUZANT
- PHESGO
Netherlands13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Poland13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Portugal13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Romania13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Slovakia13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Slovenia13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Sweden13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
Czechia13
- DAZUBLYS
- ENHERTU
- HERCEPTIN
- HERWENDA
- HERZUMA
- KADCYLA
- KANJINTI
- OGIVRI
- ONTRUZANT
- PHESGO
- TRAZIMERA
- TUZNUE
- ZERCEPAC
One answer out of three.
The atlas gives each molecule one of these three answers. Most call for nothing.
- Our formula31 molecules
- An active ingredient to consider59 molecules
- Nothing to add574 moleculesincluding this one
Do you also take another treatment?
Type the name written on the box. The atlas gives you its answer.
For example Panadol, Doliprane or paracetamol.